Dr. Brian Courtney profile photo

Dr. Brian Courtney

CEO

Toronto, ON, CA

CONAVI

Publications

Documents

Photos

photos

Audio

Video

Social

Biography

Dr. Brian Courtney is an interventional cardiologist at Sunnybrook Health Sciences Centre in Toronto, Ontario. His academic background includes Computer Engineering (BASc 1997) at the University of Waterloo, followed by a Master’s of Science in Electrical Engineering (MSEE 2000) at Stanford University. He completed his MD training (Stanford) in 2004, his internal medicine and cardiology residencies at the University of Toronto and his interventional cardiology fellowship at Sunnybrook HSC. Brian is a co-inventor on over 15 issued US patents related to medical technologies and he was a co-founder of two prior start-up companies. His research at Sunnybrook Research Institute focuses on the development of innovative medical devices and related technologies.

Areas of Expertise

Medical DevicesBiomedical EngineeringClinical ResearchCommercializationHealthcareMedical ImagingR&DDigital ImagingMedicineCardiology

Education

Stanford University School of Medicine

M.D., Medicine

2004

Stanford University

M.S.E.E., Electrical Engineering

2000

University of Waterloo

B.A.Sc., Computer Engineering

1997

Affiliations

  • Sunnybrook Health Sciences Centre : Interventional Cardiologist and Clinician Scientist

Media Appearances

Conavi Medical scores FDA approval for catheter-based Foresight ICE ultrasound system

HealthCareBusiness  online

2016-01-15

"Our goal is to provide physicians, hospitals and industry partners with new opportunities to guide the increasing number of minimally invasive procedures available for a broad range of conditions," Brian Courtney, president and CEO of Conavi Medical, told HCB News. "The imaging needs for each type of procedure vary considerably."...

view more

Conavi Medical (formerly Colibri Technologies) announces FDA 510k clearance for its first product, the Foresight ICE System for Intracardiac Echocardiography

PR Newswire  online

2016-01-14

"FDA clearance of the Foresight ICE System represents a major milestone for Conavi's team and our customers in the US healthcare system," says Brian Courtney, CEO of Conavi Medical Inc. "We look forward to working with physicians in the United States by providing them with new visualization tools to support existing and emerging minimally invasive procedures for patients with a broad range of cardiac conditions. The Foresight ICE system represents Conavi's lead product in its commercialization pipeline. The advanced technology in this system provides us with a remarkable platform from which we will be able to expand in the future to help physicians, healthcare systems and industry partners better address a large number of clinical needs."...

view more

Articles

Innovations in imaging for chronic total occlusions: a glimpse into the future of angiography's blind-spot | European Heart Journal

2008

Chronic total occlusions (CTOs) are a subset of lesions that present a considerable burden to cardiovascular patients. There exists a strong clinical desire to improve non-surgical options for CTO revascularization. While several techniques, devices, and guide ...

view more
Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III | American Heart Journal

2008

The purpose of this study was to investigate the vascular response of zotarolimus-eluting stent (ZES) and sirolimus-eluting stent (SES) using serial intravascular ultrasound (IVUS)...

view more
Assessment of coronary plaque collagen with polarization sensitive optical coherence tomography (PS-OCT) | International Journal of Cardiology

2006

Current evidence indicates that most plaques classified as vulnerable or ruptured plaque do not lead to unstable angina or myocardial infarction. Improved methods are needed to risk stratify plaques to identify those which lead to most acute coronary ...

view more
Intravascular Ultrasonic Analysis of Atherosclerotic Vessel Remodeling and Plaque Distribution of Stenotic Left Anterior Descending Coronary Arterial Bifurcation Lesions | The American Journal of Cardiology

2006

Bifurcation lesions remain a challenging lesion subset, even in the era of drug-eluting stents. The aim of this study was to investigate the longitudinal remodeling pattern and cross-sectional plaque location of bifurcation lesions. Seventy-four preintervention intravascular ultrasound studies of left anterior descending bifurcation lesions were analyzed, in which the lesion was located proximal (type A, n = 32) or distal (type B, n = 42) to the side branch. Vessel area and plaque area at the lesion (VAlesion and PAlesion) and at the reference site (VAreference and PAreference) were measured...

view more
Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis | American Heart Journal

2005

Plaque stabilization by statins is important for reduction of cardiovascular events but has not been demonstrated enough in vivo. We examined whether statins clinically alter the structure of coronary atherosclerotic plaques using intravascular ultrasound (IVUS) radio-frequency (RF) signal analysis...

view more